Recently, eIF2A knock-out mice were found to exhibit reduced longevity, dysregulated lipid metabolism, obesity, decreased glucose tolerance, and increased insulin resistance—all phenotypes of metabolic syndrome—and also decreased lymphocyte production and compromised immune tolerance, implicating eIF2A in several important physiological processes and disease states. This evidence concerns the gene EIF2A and metabolic syndrome.